Erythromycin Ethylsuccinate (Wilshire Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Erythromycin Ethylsuccinate drug offered from Wilshire Pharmaceuticals Inc.. This Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Wilshire Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Erythromycin Ethylsuccinate |
| SUBSTANCE NAME: | ERYTHROMYCIN ETHYLSUCCINATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | GRANULE, FOR SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-09-28 |
| END MARKETING DATE: | 0000-00-00 |
Erythromycin Ethylsuccinate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Erythromycin Ethylsuccinate from Wilshire Pharmaceuticals Inc. |
| LABELER NAME: | Wilshire Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/5mL) |
| START MARKETING DATE: | 2016-09-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52536-134_a3be7ce7-f431-4c5a-80f7-f66fb4097091 |
| PRODUCT NDC: | 52536-134 |
| APPLICATION NUMBER: | NDA050207 |
Other ERYTHROMYCIN ETHYLSUCCINATE Pharmaceutical Manufacturers / Labelers:
